.jpeg)
Where to buy Vandetanib
Vandetanib (Vandetanib) is an anti-cancer drug known as an anti-tumor kinase inhibitor. The U.S. Food and Drug Administration (FDA) approved vandetanib in April 2011 for the treatment of unresectable, locally advanced, or metastatic medullary thyroid cancer in adults. It was sold under the trade name Caprelsa after its launch. The original drug vandetanib has not yet been launched in China, so domestic patients cannot yet purchase it through domestic channels. The original drug of Vandetanib listed overseas may cost more than 30,000 yuan per box of 300mg*30 tablets (the price may fluctuate due to exchange rates). Currently, there is no generic version of Vandetanib on the market. For more drug information and specific prices, please consult the medical consultant of Yaode.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
